Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Brimonidine/Timolol and Dorzolamide/Timolol in Glaucoma or Ocular Hypertension
NCT00822055Phase 4Completed
- Sponsor
- Allergan
- Start
- May 2005
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of brimonidine tartrate + timolol maleate in open-angle glaucoma (OAG) and ocular hypertension (4 arms), sponsored by Allergan. Primary endpoint: Change from baseline in mean Intraocular Pressure at 12 weeks. Started May 2005; status: completed.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00822055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822055.